Breaking News Instant updates and real-time market news.

ABMD

Abiomed

$210.15

2.01 (0.97%)

05:15
01/12/18
01/12
05:15
01/12/18
05:15

Abiomed price target raised to $250 from $220 at Jefferies

Jefferies analyst Raj Denhoy raised his price target for Abiomed to $250 after hosting a dinner with management. The company "remains the cleanest growth story in our coverage and looks far from done," Denhoy tells investors in a research note. He says the company's shock and percutaneous coronary intervention indications continue to support "best-in-class growth" and that new markets and new technologies will see progress in 2018. Competition for Abiomed remains nonexistent, the analyst adds. He keeps a Buy rating on the shares.

  • 01

    Feb

ABMD Abiomed
$210.15

2.01 (0.97%)

10/16/17
BTIG
10/16/17
DOWNGRADE
BTIG
Neutral
Abiomed downgraded to Neutral from Buy at BTIG
BTIG analyst Sean Lavin downgraded Abiomed to Neutral from Buy citing valuation after the stock's 70% move higher over the last year. He feels that at over $170 shares are fairly valued and may be pricing in strong quarterly results and a successful STEMI DTU trial.
10/26/17
PIPR
10/26/17
NO CHANGE
Target $200
PIPR
Overweight
Abiomed price target raised to $200 from $160 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for Abiomed to $200 and "strongly" encourages investorts to build positions in the shares at current levels. The analyst views today's Q2 results as "impressive" and feels the company's earnings power is among the best in medical technology. O'Brien keeps an Overweight rating on Abiomed.
12/21/17
JEFF
12/21/17
NO CHANGE
JEFF
Jefferies lays out top 2018 ideas in Medical Supplies & Devices
Jefferies analyst Raj Denhoy calls Haemonetics (HAE), AxoGen (AXGN), Abbott (ABT) and Hologic (HOLX) his top Medical Supplies & Devices ideas to start 2018. Following a year of strong device performance in 2017, the analyst believes 2018 is "looking like more of the same." Denhoy raised his price target for Abiomed (ABMD) to $220, for Dexcom (DXCM) to $70, for Haemonetics to $68, for Hologic to $52, for LivaNova (LIVN) to $94, for Varex Imaging (VREX) to $44 and for Zimmer Biomet (ZBH) to $140. The analyst has Buy ratings on all of those stocks.
01/04/18
PIPR
01/04/18
NO CHANGE
Target $220
PIPR
Overweight
Piper says buy Abiomed at these levels, ups price target to $220
Piper Jaffray analyst Matt O'Brien raised his price target for Abiomed to $220 from $200 and says the shares should be bought, "even at these levels." Investors do not fully comprehend the importance of a surgeon led "Call to Action" to improve outcomes in cardiogenic shock rates, which have not improved in 20 years, O'Brien tells investors in a research note. The analyst continues to believe Abiomed is the best "open-ended growth story" in all of med tech and he "strongly" recommends investors start or build positions in the name.

TODAY'S FREE FLY STORIES

BBY

Best Buy

$77.86

-1.55 (-1.95%)

09:28
09/26/18
09/26
09:28
09/26/18
09:28
Recommendations
Best Buy analyst commentary  »

Argus looking for entry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
09/26/18
09/26
09:25
09/26/18
09:25
Conference/Events
Cowen retail analysts to hold an analyst/industry conference call »

Retail & Consumer…

BPY

Brookfield Property

$20.83

0.18 (0.87%)

, BBU

Brookfield Business Partners

$42.69

-0.12 (-0.28%)

09:25
09/26/18
09/26
09:25
09/26/18
09:25
Conference/Events
Brookfield to hold investor day »

Investor Day to be held…

BPY

Brookfield Property

$20.83

0.18 (0.87%)

BBU

Brookfield Business Partners

$42.69

-0.12 (-0.28%)

BAM

Brookfield

$44.50

0.37 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

USG

USG

$43.23

-0.04 (-0.09%)

09:25
09/26/18
09/26
09:25
09/26/18
09:25
Conference/Events
USG to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

09:22
09/26/18
09/26
09:22
09/26/18
09:22
Technical Analysis
Technical Take: KB Home rallies sharply after earnings news, analyst action »

The company reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFO

IHS Markit

$53.89

-0.37 (-0.68%)

09:21
09/26/18
09/26
09:21
09/26/18
09:21
Recommendations
IHS Markit analyst commentary  »

IHS Markit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAX

Baxter

$77.47

-0.3 (-0.39%)

09:20
09/26/18
09/26
09:20
09/26/18
09:20
Hot Stocks
Baxter announces FDA clearance of Altapore Bioactive Bone Graft »

Baxter International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

JPM

JPMorgan

$116.40

-0.32 (-0.27%)

, GS

Goldman Sachs

$232.39

-0.46 (-0.20%)

09:20
09/26/18
09/26
09:20
09/26/18
09:20
Periodicals
JPMorgan in discussion to lead Lyft's IPO, Reuters reports »

JPMorgan (JPM) is in…

JPM

JPMorgan

$116.40

-0.32 (-0.27%)

GS

Goldman Sachs

$232.39

-0.46 (-0.20%)

MS

Morgan Stanley

$48.28

-0.28 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Sep

  • 01

    Oct

  • 02

    Oct

  • 12

    Oct

  • 16

    Oct

  • 21

    Oct

  • 26

    Feb

EROS

Eros International

$12.73

0.375 (3.04%)

09:19
09/26/18
09/26
09:19
09/26/18
09:19
Hot Stocks
Eros International enters into strategic partnership with Fashion TV »

Eros International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
09/26/18
09/26
09:18
09/26/18
09:18
Options
Overnight activity included 198 trades in SPX and 1 trades in VIX »

198 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERI

Eldorado Resorts

$47.80

-0.55 (-1.14%)

09:17
09/26/18
09/26
09:17
09/26/18
09:17
Hot Stocks
Eldorado Resorts announces senior management transition »

Eldorado Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBLK

Star Bulk Carriers

$13.10

-0.13 (-0.98%)

09:17
09/26/18
09/26
09:17
09/26/18
09:17
Conference/Events
Star Bulk Carriers management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TEN

Tenneco

$42.98

-1.61 (-3.61%)

09:17
09/26/18
09/26
09:17
09/26/18
09:17
Conference/Events
Tenneco management to meet with RBC Capital »

Group Luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TGTX

TG Therapeutics

$5.13

-4.125 (-44.59%)

09:16
09/26/18
09/26
09:16
09/26/18
09:16
Recommendations
TG Therapeutics analyst commentary  »

TG Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

INGR

Ingredion

$103.63

0.88 (0.86%)

09:16
09/26/18
09/26
09:16
09/26/18
09:16
Hot Stocks
Ingredion to invest $60M in specialty food ingredients in Asia-Pacific »

Ingredion announced $60M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

09:14
09/26/18
09/26
09:14
09/26/18
09:14
Technical Analysis
Technical Take: Nike falls after earnings »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOS

Kosmos

$9.65

0.18 (1.90%)

09:14
09/26/18
09/26
09:14
09/26/18
09:14
Downgrade
Kosmos rating change  »

Kosmos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$19.88

-0.525 (-2.57%)

09:13
09/26/18
09/26
09:13
09/26/18
09:13
Hot Stocks
AMC Theatres says AMC Stubs A-List has passed 380,000 members »

AMC Theatres announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

GDS

GDS Holdings

$34.98

0.97 (2.85%)

09:13
09/26/18
09/26
09:13
09/26/18
09:13
Conference/Events
GDS Holdings management to meet with RBC Capital »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

OBLN

Obalon Therapeutics

$2.61

0.09 (3.57%)

09:12
09/26/18
09/26
09:12
09/26/18
09:12
Hot Stocks
Obalon Therapeutics announces approval of PMA-S application for Obalon Touch »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

IBM

IBM

$148.91

-1.09 (-0.73%)

09:12
09/26/18
09/26
09:12
09/26/18
09:12
Technical Analysis
Technical Take: IBM rises, analyst action »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

FIS

FIS

$109.81

-0.15 (-0.14%)

09:11
09/26/18
09/26
09:11
09/26/18
09:11
Conference/Events
FIS management to meet with Deutsche Bank »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

  • 13

    Nov

PFPT

Proofpoint

$107.00

2.96 (2.85%)

09:10
09/26/18
09/26
09:10
09/26/18
09:10
Recommendations
Proofpoint analyst commentary  »

Proofpoint checks point…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 11

    Oct

  • 16

    Oct

  • 06

    Nov

  • 13

    Nov

  • 10

    Dec

NKE

Nike

$84.79

0.52 (0.62%)

, ALDX

Aldeyra

$9.88

0.325 (3.40%)

09:09
09/26/18
09/26
09:09
09/26/18
09:09
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Aldeyra (ALDX),…

NKE

Nike

$84.79

0.52 (0.62%)

ALDX

Aldeyra

$9.88

0.325 (3.40%)

GPRO

GoPro

$6.63

0.25 (3.92%)

VSTM

Verastem

$7.15

-1.74 (-19.57%)

KMX

CarMax

$75.87

-0.01 (-0.01%)

DGLY

Digital Ally

$3.75

-0.275 (-6.83%)

CONE

CyrusOne

$64.65

-0.6 (-0.92%)

NLST

Netlist

$0.65

-0.0339 (-4.95%)

CIEN

Ciena

$31.32

-0.025 (-0.08%)

KBH

KB Home

$25.29

-0.24 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 04

    Oct

  • 05

    Oct

  • 05

    Oct

  • 06

    Nov

  • 26

    Sep

  • 26

    Sep

BANR

Banner Corp.

$64.03

-0.07 (-0.11%)

09:09
09/26/18
09/26
09:09
09/26/18
09:09
Hot Stocks
Banner Corp. increases quarterly dividend 9% to 38c per share »

Banner Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.